Access



not registered? click here

 
Learn More about:
Our Founders >>

Recent Studies >>
 

company

 
 

 

Mission Statement

 

CEO

 

Our Vision

 

Our Team

 

Strategic Partners

 

PKC is constantly developing strategic partnerships with major medical device and pharmaceutical companies, and is in discussions with physicians and researchers at academic institutions and major cancer centers to establish research and commercial partnerships as the product portfolio is developed.

 

For more information or to inguire about partnering with PKC, please email us at: info@pharmaco-kinesis.com

 

 

UCSD

The University California, San Diego (UCSD) is one of the world's leading public research universities, located in beautiful La Jolla, California. PKC and  USCD have agreed to pursue joint human trials for PKC's MBP technology.

visit website

USC

The University of Southern California (USC) is one of the world's leading private research universities, located in the heart of Los Angeles. PKC and USCD have agreed to pursue joint human trials for PKC's MBP technology.

visit website

Cleveland Clinic

Located in Cleveland, Ohio, Cleveland Clinic is a nonprofit, multispecialty academic medical center that integrates clinical and hospital care with research and education. The Cleveland Clinic is one of the largest and most respected hospitals in the country. PKC and the Cleveland Clinic have agreed to pursue joint human trials for PKC's MBP technology.

visit website

University Centrum fürTumorerkrankungen

NCT is a comprehensive cancer center located in Heidelberg, Germany. NCT has been adapted to the German health care system and is noted for its comprehensive and interdisciplinary approach, providing all relevant aspects for a successful fight against cancer. PKC and NCI have agreed to pursue joint human trials for PKC's MBP technology.

visit website

University Clinic Hamburg-Eppendorf

The University Medical Center Hamburg-Eppendorf is the largest hospital in Hamburg with approximately 1460 hospital beds. Each year the medical center treats around 80 000 in-patients. Additionally, approximately 260 000 out-patients as well as 113 000 emergency patients are treated. In addition it has one of the largest research and clinical testing facilities in the area. PKC and NCI have agreed to pursue joint human trials for PKC's MBP technology.

visit website

Sandoz Logo

Sandoz, the generic pharmaceuticals division of Novartis, is a worldwide leader in generic formulations. With a history of more than 120 years, Sandoz is a trusted leader with a reputation for exceptional quality. Their combination of specialist expertise and extensive global presence, underpinned by an unwavering commitment to quality, gives them a competitive advantage that clearly sets us apart from the competition. Under strategic collaborative efforts between Sandoz and PKC, PKC will utilize Sandoz Methotrexate drug to be use in PKC Metronomic Biofeedback Pump (MBP). The first in human clinical trials is scheduled to be commenced in ten sites in Germany in Q4 2014. Under this strategic collaborative partnership Sandoz will develop the reformulated Methotrexate that will be stabilized at body temperature for first disease indication for patients with Leptomeningeal Carcinomatosis.

visit website

The PKC Family of Companies brings together over 25 years of proven experience in meeting the needs of a divergent range of clients. Watch Overview Video.

visit website

The BIRD Foundation's mission is to stimulate, promote and support industrial R&D of mutual benefit to the U.S. and Israel.

visit website

Milouot, founded in 1960, is a conglomerate of factories and companies with the fundamental cooperative ideals of the owner-settlements, with each contributing its abilities and expertise towards Milouot’s economic undertakings.

Watch Overview video.
visit website

Pharmaco-Kinesis has made a presentation of MBP technology to the Sloan-Kettering Cancer Center. PKC intends to make a collaborative effort to conduct possible human trial using MPB in conjunction with SKCC.

visit website

 

 

 

 

 

 

 

 

 

 

 



 
 
  main: 310.641.2700 fax: 310.641.2702 6053 W Century Blvd, Suite 1000, Los Angeles, CA 90045-6400 © Pharmaco Kinesis Corp.